SUBSCRIBER ONLY
Are solar panels a good investment? New study offers an answer
A new study of 500,000 households offers the best snapshot to date on estimated savings of rooftop solar for American consumers.
All Stories
Another COVID vaccine? Yes, and here's why
Last year's shot isn't holding up. Next fall's vaccine offers several important benefits.
One of world’s rarest whales seen off California coast
In an extraordinary sighting, a critically endangered North Pacific right whale was spotted off the California coast on Friday, thrilling scientists.
Breakthrough therapies are saving lives. Can we afford them?
This is the future of medicine, experts agree. But the cost of this new class of medical treatment is raising alarm about availability and affordability, even as its potential grows.
Our brains are growing. Will that help prevent dementia?
UC Davis study finds brain size has steadily increased for people born after the 1930s.
Hidden COVID virus found more than a year after infection
A clue to long COVID? UCSF discovery of persistent viral fragments could guide the search for treatment.
SUBSCRIBER ONLY
Long Covid creates changes in the blood, aiding detection, reports new study
A shifting pattern of proteins, showing immune dysregulation, could help efforts to create diagnostic tests and treatment.
Who will need a Yosemite reservation as park revives restrictions
Overwhelmed by last year’s crowds, Yosemite National Park will limit entry next spring, summer and fall.
New psychedelic-like drugs: All treatment, no 'trip'?
California scientists race to concoct compounds that rewire the brain without euphoria or hallucinations.
Psychedelic drugs: Follow the money as investors seek to replace Prozac, Zoloft and other drugs
Biotech startups and venture capital funds are investing in once-controversial treatments.